Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 May 11;16:3275–3292. doi: 10.2147/IJN.S296398

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 Liu et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Immunofluorescence showing the changes in activation of spinal cord astrocytes and microglia from different treatment groups after one day of treatment. (A) Changes in astrocyte marker GFAP; (B) Changes in microglial marker IBA-1. The picture shows the right dorsal horn of the spinal cord on a scale of 50 μm. (C) Number of positive cells of GFAP. Compared with CCI group, ***P < 0.001. (D) Number of positive cells of IBA-1. Compared with CCI group,*P < 0.05, ***P < 0.001.